Literature DB >> 6851409

Placental transfer and maternal midazolam kinetics.

J Kanto, S Sjövall, R Erkkola, J J Himberg, L Kangas.   

Abstract

Midazolam was given in a single 15-mg oral dose as a sedative the evening before elective cesarean section. Twelve hours later, levels of this new benzodiazepine were measureable in the fetomaternal entity in only one of 13 cases. After 15 mg midazolam orally or 0.05 mg/kg midazolam intramuscularly 15 to 60 min before elective cesarean section, there was evident transfer of drug into the placenta, but transfer took place more slowly than with diazepam. On the basis of kinetics derived from maternal serum concentrations after oral, intramuscular, or intravenous dosing, midazolam appears to have a rapid onset and short duration of action, which was also evident from subjective assessments by the patients. There was wide interindividual variation in the gastrointestinal absorption of midazolam in full-term pregnant women. Clinically, midazolam nevertheless seemed to be very useful for nocturnal sedation before elective cesarean section; it ensures a mean duration of sleep of about 6 hr and there are virtually no detectable levels of drug in the fetomaternal entity the next morning.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6851409     DOI: 10.1038/clpt.1983.107

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN: 0009-9236            Impact factor:   6.875


  14 in total

1.  Anatomical, physiological and metabolic changes with gestational age during normal pregnancy: a database for parameters required in physiologically based pharmacokinetic modelling.

Authors:  Khaled Abduljalil; Penny Furness; Trevor N Johnson; Amin Rostami-Hodjegan; Hora Soltani
Journal:  Clin Pharmacokinet       Date:  2012-06-01       Impact factor: 6.447

Review 2.  Hepatic drug metabolism and aging.

Authors:  C Durnas; C M Loi; B J Cusack
Journal:  Clin Pharmacokinet       Date:  1990-11       Impact factor: 6.447

3.  Development of a Novel Maternal-Fetal Physiologically Based Pharmacokinetic Model I: Insights into Factors that Determine Fetal Drug Exposure through Simulations and Sensitivity Analyses.

Authors:  Zufei Zhang; Marjorie Z Imperial; Gabriela I Patilea-Vrana; Janak Wedagedera; Lu Gaohua; Jashvant D Unadkat
Journal:  Drug Metab Dispos       Date:  2017-06-06       Impact factor: 3.922

4.  Development of a Novel Maternal-Fetal Physiologically Based Pharmacokinetic Model II: Verification of the model for passive placental permeability drugs.

Authors:  Zufei Zhang; Jashvant D Unadkat
Journal:  Drug Metab Dispos       Date:  2017-01-03       Impact factor: 3.922

5.  [Analytic data of the new benzodiazepine derivative midazolam (Dormicum) and its metabolites].

Authors:  H Schütz
Journal:  Z Rechtsmed       Date:  1985

Review 6.  Anaesthetic premedication: aims, assessment and methods.

Authors:  T H Madej; R T Paasuke
Journal:  Can J Anaesth       Date:  1987-05       Impact factor: 5.063

Review 7.  Placental transfer of drugs administered to the mother.

Authors:  G M Pacifici; R Nottoli
Journal:  Clin Pharmacokinet       Date:  1995-03       Impact factor: 6.447

Review 8.  Obstetric analgesia. Clinical pharmacokinetic considerations.

Authors:  J Kanto
Journal:  Clin Pharmacokinet       Date:  1986 Jul-Aug       Impact factor: 6.447

Review 9.  Risk-benefit assessment of anaesthetic agents in the puerperium.

Authors:  J Kanto
Journal:  Drug Saf       Date:  1991 Jul-Aug       Impact factor: 5.606

10.  Midazolam and nitrazepam in the maternity ward: milk concentrations and clinical effects.

Authors:  I Matheson; P K Lunde; J E Bredesen
Journal:  Br J Clin Pharmacol       Date:  1990-12       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.